TriTACs, a Novel Class of T-Cell–Engaging Protein Constructs Designed for the Treatment of Solid Tumors
2020 · Molecular Cancer Therapeutics · 55 citations
https://doi.org/10.1158/1535-7163.mct-20-0061
M
Manasi Barath
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
78
Papers
198
Citations
8
h-index
5
i10-index
Manasi Barath is an academic researcher from Rapt Therapeutics (United States). The author has contributed to research in topics: CAR-T cell therapy research & Cancer Immunotherapy and Biomarkers & Monoclonal and Polyclonal Antibodies Research. The author has an h-index of 8, co-authored 67 publications.
ORCID: 0009-0004-7062-6452Papers by this author
worksFigure S11 from HPN328, a Trispecific T Cell–Activating Protein Construct Targeting DLL3-Expressing Solid Tumors
2024 · 0 citations
https://doi.org/10.1158/1535-7163.26934659.v1
Figure S12 from HPN328, a Trispecific T Cell–Activating Protein Construct Targeting DLL3-Expressing Solid Tumors
2024 · 0 citations
https://doi.org/10.1158/1535-7163.26934656.v1
Figure S4 from HPN328, a Trispecific T Cell–Activating Protein Construct Targeting DLL3-Expressing Solid Tumors
2024 · 0 citations
https://doi.org/10.1158/1535-7163.26934626
Figure S13 from HPN328, a Trispecific T Cell–Activating Protein Construct Targeting DLL3-Expressing Solid Tumors
2024 · 0 citations
https://doi.org/10.1158/1535-7163.26934653.v1
Figure S3 from HPN328, a Trispecific T Cell–Activating Protein Construct Targeting DLL3-Expressing Solid Tumors
2024 · 0 citations
https://doi.org/10.1158/1535-7163.26934629
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat